Form 8-K JUNIPER PHARMACEUTICALS For: May 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St set to open lower as oil jump, high yields fuel inflation concerns
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Lynx sees AI semiconductor rally extending into year-end
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Juniper Pharma (JNP) Tops Q1 EPS by 11c
May 4, 2016 7:58 AM EDTJuniper Pharma (NASDAQ: JNP) reported Q1 EPS of $0.03, $0.11 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $12.1 million versus the consensus estimate of $9.13 million.
For earnings history and earnings-related data on Juniper Pharma (JNP) click here.
... More


